Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MYOMO, INC.MYO · Entity 7135 | Chief Medical Officer | September 11, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MYOMO, INC.
Report date September 11, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,245 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Sale · Disposed 15,488 · Balance 90,245 F1: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 14, 2026 20:30 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 15,488 | $1.27 | $19,683.70 |
DisclosureSEC source: 0001193125-26-390646 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,245 F1 · price: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $1.25 to $1.29 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 20, 2026 Filed Aug 21, 2026 22:17 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 17,250 | $1.73 | $29,895.98 |
DisclosureSEC source: 0001193125-26-361391 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,983 F1 · price: Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 12:08 UTC Amendment | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 17,500 | $1.73 | $30,329.25 |
DisclosureSEC source: 0001193125-26-361870 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,733 F1 · price: Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 12:07 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 22,457 | $1.42 | $31,888.94 |
DisclosureSEC source: 0001193125-26-343483 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,233 F2 · shares: Represents shares withheld solely to pay income and other taxes associated with the aforementioned vesting of RSU's granted on August 7, 2026. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 12:07 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 55,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-343483 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,690 F1 · shares: Represents a grant of fully vested Restricted Stock Units ("RSU's") as payment for incentive compensation for the Reporting Party earned for the fiscal year ended December 31, 2025. Read SEC document |
| June 12, 2026 Filed Jun 12, 2026 21:06 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 10,442 | $1.20 | $12,530.40 |
DisclosureSEC source: 0001193125-26-269675 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,541 F1 · shares: Represents shares sold on June 12, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 11, 2026, purusant to an irrevocable election made by the Reporting Party on May 28, 2026. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:38 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 7,635 | $1.33 | $10,154.55 |
DisclosureSEC source: 0001193125-26-263886 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,983 F1 · shares: Represents shares sold on June 8, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 5, 2026. Read SEC document |
| May 28, 2026 Filed May 29, 2026 01:53 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 11,536 | $1.02 | $11,734.42 |
DisclosureSEC source: 0001193125-26-245953 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,618 F1 · shares: Represents open market sale of shares. F3 · price: Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.035 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| May 27, 2026 Filed May 29, 2026 01:53 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 20,464 | $1.00 | $20,504.93 |
DisclosureSEC source: 0001193125-26-245953 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,154 F1 · shares: Represents open market sale of shares. F2 · price: Represents weighted average sales price. Shares were sold in multiple lots at prices ranging from $1.00 to $1.005 per share. Reporting party agrees to provide details of the transactions to the SEC upon request. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 12:20 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 13,054 | $2.19 | $28,588.26 |
DisclosureSEC source: 0000950170-25-092544 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,618 F1 · shares: Represents sale of shares on June 30, 2025, solely to cover income taxes on the vesting of restricted stock units on June 28, 2025, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:14 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 62,938 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086369 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,672 F1 · shares: Represents grant of Restricted Stock Units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 11, 2026. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 23:46 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 5,743 | $2.97 | $17,056.71 |
DisclosureSEC source: 0000950170-25-083376 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,734 F1 · shares: Represents sale of shares on June 6, 2025 solely to cover income taxes on the vesting of restricted stock units ("RSU's") on June 5, 2025 under the Issuer's 2018 Stock Option and Incentive Plan, pursuant to an irrevocable election made by the Reporting Party on May 12, 2025. Read SEC document |
| March 13, 2025 Filed Mar 13, 2025 20:41 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 1,496 | $5.22 | $7,809.12 |
DisclosureSEC source: 0000950170-25-038823 · ownership.xml · nonDerivative · entry 3 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,477 F4 · shares: Shares sold on March 13, 2025 solely to cover income taxes on a vesting of restricted stock units on March 11, 2025, pursuant to an irrevocable election made by the Reporting Party on March 11, 2025. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:41 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 30,000 | $5.50 | $165,018.00 |
DisclosureSEC source: 0000950170-25-038823 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,973 F2 · shares: Represents sale of shares in an open market transaction F3 · price: Represents average sales price. Transactions were completed in multiple lots at prices ranging from $5.50 to $5.53 per share. Reporting Party agrees to provide details of the trades to the SEC upon request. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:41 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 3,553 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038823 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,973 F1 · shares: Represents grant of restricted stock units ("RSU's") on March 11, 2025 under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's became fully vested on the grant date. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:36 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 121 | $3.70 | $447.70 |
DisclosureSEC source: 0000950170-24-121547 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,314 F1 · shares: Represents sale of shares on November 4, 2024 solely to cover income taxes due on the vesting of restricted stock units on November 2, 2024, pursuant to an irrevocable election made by the Reporting Porty in conjunction with the original grant in November 2020. Read SEC document |
| October 03, 2024 Filed Oct 4, 2024 20:20 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 121 | $3.86 | $467.06 |
DisclosureSEC source: 0000950170-24-112915 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,435 F1 · shares: Represents sale of shares solely to cover income taxes due on the vesting of restricted stock units on October 2, 2024, pursuant to an irrevocable election made by the Reporting Porty in conjunction with the original grant in November 2020. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:04 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 6,700 | $3.76 | $25,182.62 |
DisclosureSEC source: 0000950170-24-104735 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,556 F1 · price: Represents volume weighted average sales price. Shares were sold in multiple lots, at prices ranging from $3.74 to $3.83 per share, in open market transactions. Reporting Party agrees to provide details of the individual transactions to the SEC upon request. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 12:27 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 139 | $3.89 | $540.71 |
DisclosureSEC source: 0000950170-24-103753 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,256 F2 · shares: Shares were sold on September 4, 2024 solely to cover income taxes on the vesting of restricted stock units on September 2, 2024, pursuant to an irrevocable election made by the Reporting Party in November 2020. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 12:27 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 2,029 | $4.01 | $8,140.35 |
DisclosureSEC source: 0000950170-24-103753 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,395 F1 · price: Represents volume weighted average sales price. Shares were sold in multiple lots, at prices ranging from $4.00 to $4.03 per share, in open market transactions. Reporting Party agrees to provide details of the individual transactions to the SEC upon request. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 01:50 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 128 | $3.96 | $506.88 |
DisclosureSEC source: 0000950170-24-093230 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,424 F1 · shares: Shares sold on August 5, 2024 solely to pay income taxes resulting from the vesting a restricted stock unit grant on August 2, 2024, pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 20:44 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 121 | $2.85 | $344.85 |
DisclosureSEC source: 0000950170-24-082149 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,552 F1 · shares: Shares sold on July 3, 2024 solely to pay income taxes resulting from the vesting a restricted stock unit grant on July 2, 2024, pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 00:09 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 12,868 | $3.02 | $38,861.36 |
DisclosureSEC source: 0000950170-24-080990 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,673 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting a restricted stock unit grant on June 28, 2024, pursuant to an irrevocable election made by the Reporting Party on May 12, 2024. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 20:12 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 5,347 | $3.38 | $18,067.51 |
DisclosureSEC source: 0000950170-24-072450 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,541 F1 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 12, 2024. F2 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. Read SEC document |
| June 10, 2024 Filed Jul 3, 2024 00:28 UTC Amendment | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 5,347 | $3.38 | $18,067.51 |
DisclosureSEC source: 0000950170-24-081005 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,541 F2 · shares: Shares sold solely to pay income taxes resulting from the vesting of multiple restricted stock unit grants on June 8 and June 9, 2024, pursuant to an irrevocable election made by the Reporting Party on May 12, 2024. F3 · price: Represents the average selling price. Shares were sold in multiple lots at prices ranging from $3.33 to $3.39 per share. The Reporting Party agrees to provide detials of the transactions to the SEC upon request. F1 · acquired: This amendment corrects the coding of this transaction from an acquisition in the original filing on June 12, 2024 to a disposition. No other changes to this Form. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:02 UTC | MYOMO, INC. MYO · Entity 7135 | Exercise / conversionRestricted Stock Units · Derivative | 1,235 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008872 · ownership.xml · derivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,235 shares Expires 2024-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.underlying_shares: Represents performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive Plan. 1,235 shares were earned based on the Company's relative stock price performance from June 10, 2021 to March 9, 2024 compared to a peer group of companies, which are reported in Table I of this report on Form 4. The remaining 6,965 restricted stock units granted expired unvested. Read SEC document |
| June 09, 2024 Filed Jan 24, 2025 22:02 UTC | MYOMO, INC. MYO · Entity 7135 | Exercise / conversionCommon Stock | 1,235 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008872 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:47 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-070787 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,888 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in annual installments over three years beginning on June 5, 2025. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:52 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 121 | $3.48 | $421.08 |
DisclosureSEC source: 0000950170-24-069474 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,888 F1 · price: Represents shares sold on June 3, 2024 solely to cover income taxes resulting from the vesting of restricted stock units on June 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:57 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 35,426 | $3.69 | $130,838.85 |
DisclosureSEC source: 0000950170-24-061827 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,009 F1 · price: Represents average sales price. Sales were transacted in multiple lots at prices ranging from $3.60 to $3.76 per share. Reporting Party agrees to provide detials of the trades to the SEC upon request. Read SEC document |
| May 03, 2024 Filed May 6, 2024 21:10 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 146 | $3.84 | $560.64 |
DisclosureSEC source: 0000950170-24-053682 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,435 F1 · shares: Represents shares sold on May 3, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on May 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 21:50 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 146 | $2.97 | $433.62 |
DisclosureSEC source: 0000950170-24-041921 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,581 F1 · shares: Represents shares sold on April 3, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on April 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:32 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 6,590 | $3.51 | $23,130.90 |
DisclosureSEC source: 0000950170-24-030821 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,727 F1 · shares: Represents shares sold on March 11, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on March 8, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party on March 8, 2024. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 12:21 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 147 | $3.88 | $570.36 |
DisclosureSEC source: 0000950170-24-026872 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,317 F1 · shares: Represents shares sold on March 5, 2024 solely to pay income taxes on the vesting of restricted stock units on March 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:34 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 146 | $3.21 | $468.66 |
DisclosureSEC source: 0000950170-24-011407 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,464 F1 · shares: Represents shares sold on February 5, 2024 solely to pay income taxes on the vesting of restricted stock units on February 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 23:03 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 145 | $4.69 | $680.05 |
DisclosureSEC source: 0000950170-24-002078 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,610 F1 · shares: Represents shares sold on January 3, 2024 solely to pay income taxes resulting from the vesting of restricted stock units on January 2, 2024. Transaction was completed pursuant to an irrevocable election made by the Reporting Party in conjunction with the original grant in November 2020. Read SEC document |
| December 05, 2023 Filed Dec 5, 2023 22:56 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 99 | $4.02 | $397.98 |
DisclosureSEC source: 0000950170-23-068302 · ownership.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,755 F2 · shares: Represents shares sold on December 5, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on December 2, 2023. Transaction was completed pursusnt to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:56 UTC | MYOMO, INC. MYO · Entity 7135 | SaleCommon Stock | 8,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-068302 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,854 F1 · price: Shares sold in multiple lots at sale prices ranging from $3.122 to $3.13 per share. Reporting party agrees to provide details of the transactions to a Myomo shareholder or the SEC upon request. Read SEC document |
| November 06, 2023 Filed Nov 6, 2023 23:42 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 121 | $1.41 | $170.61 |
DisclosureSEC source: 0000950170-23-059604 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,187 F1 · shares: Represents shares sold on November 6, 2023 soley to pay income taxes resulting from the vesting of restricted stock units on November 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020 Read SEC document |
| October 03, 2023 Filed Oct 3, 2023 21:34 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 123 | $1.10 | $135.30 |
DisclosureSEC source: 0000950170-23-051684 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,308 F1 · shares: Represents shares sold on October 3, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on October 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 22:47 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 125 | $0.87 | $108.75 |
DisclosureSEC source: 0000950170-23-046821 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,431 F1 · shares: Represents shares sold on September 5, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on September 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 21:00 UTC | MYOMO, INC. MYO · Entity 7135 | PurchaseCommon Stock | 8,333 | $0.60 | $4,999.80 |
DisclosureSEC source: 0000950170-23-045501 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,556 F1 · shares: Represents purchase of common stock as part of a public offering under Form S-3 by the Registrant, which closed on August 29, 2023 Read SEC document |
| August 29, 2023 Filed Jan 12, 2024 22:43 UTC Amendment | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 8,333 | $0.60 | $4,999.80 |
DisclosureSEC source: 0000950170-24-004311 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,556 F1 · shares: Represents purchase of shares as part of a public offering by the Regsitrant under Form S-3, which closed on August 29, 2023. Read SEC document |
| August 03, 2023 Filed Aug 3, 2023 21:41 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 125 | $0.71 | $88.75 |
DisclosureSEC source: 0000950170-23-038163 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,223 F1 · shares: Represents shares sold on August 3, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on August 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| July 05, 2023 Filed Jul 5, 2023 20:54 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 109 | $0.60 | $65.40 |
DisclosureSEC source: 0001209191-23-041159 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,348 F1 · shares: Represents shares sold on July 5, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on July 2, 2023. Transaction was completed based on an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:36 UTC | MYOMO, INC. MYO · Entity 7135 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040341 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,457 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 28, 2024. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 22:10 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 499 | $0.46 | $230.09 |
DisclosureSEC source: 0001209191-23-036463 · doc4.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,328 F1 · shares: Represents shares withheld solely to pay income taxes resulting from vesting of restricted stock units on June 8 and June 9, 2023. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 22:10 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 5,105 | $0.46 | $2,363.62 |
DisclosureSEC source: 0001209191-23-036463 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,827 F1 · shares: Represents shares withheld solely to pay income taxes resulting from vesting of restricted stock units on June 8 and June 9, 2023. Read SEC document |
| June 06, 2023 Filed Jun 6, 2023 20:18 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 125 | $0.55 | $68.75 |
DisclosureSEC source: 0001209191-23-034753 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,932 F1 · shares: Represents shares sold on June 6, 2023 solely to pay income taxes resulting from vesting of restricted stock units on June 2, 2023, pursuant to an irrevocable arrangement between the Reporting Person and the Issuer. Read SEC document |
| May 03, 2023 Filed May 3, 2023 21:16 UTC | MYOMO, INC. MYO · Entity 7135 | Tax withholdingCommon Stock | 131 | $0.55 | $72.05 |
DisclosureSEC source: 0001209191-23-027066 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,057 F1 · shares: Represents shares sold on May 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on May 2, 2023, pursuant to an irrevocable arrangement between the Reporting Person and the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.